Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.14 AUD | +5.34% | +6.15% | +117.89% |
Apr. 24 | Clarity Pharmaceuticals Completes AU$10.8 Million Retail Entitlement Offer | MT |
Apr. 04 | Clarity Pharmaceuticals Signs Supply Agreement with NorthStar Medical Radioisotopes | MT |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 1.29B 858M |
---|---|---|---|---|---|
Net income 2024 * | -37M -24.65M | Net income 2025 * | -48M -31.98M | EV / Sales 2024 * | - |
Net cash position 2024 * | 131M 87.16M | Net cash position 2025 * | 89.22M 59.45M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-31.8
x | P/E ratio 2025 * |
-24.5
x | Employees | 41 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.91% |
1 day | +5.34% | ||
1 week | +6.15% | ||
Current month | +47.86% | ||
1 month | +53.90% | ||
3 months | +61.09% | ||
6 months | +245.00% | ||
Current year | +117.89% |
Managers | Title | Age | Since |
---|---|---|---|
Colin Biggin
CEO | Chief Executive Officer | - | 16-12-31 |
Matthew Harris
FOU | Founder | - | 09-12-31 |
David Green
DFI | Director of Finance/CFO | - | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chris Roberts
BRD | Director/Board Member | 70 | - |
Robert Thomas
BRD | Director/Board Member | 79 | 21-08-24 |
Thomas Ramdahl
BRD | Director/Board Member | 68 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 4.14 | +5.34% | 1 575 053 |
24-05-16 | 3.93 | +2.34% | 861,682 |
24-05-15 | 3.84 | -2.54% | 777,031 |
24-05-14 | 3.94 | -0.76% | 966,919 |
24-05-13 | 3.97 | +1.79% | 1,597,866 |
Delayed Quote Australian S.E., May 17, 2024 at 02:10 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+117.89% | 816M | |
+8.29% | 114B | |
+10.21% | 104B | |
-11.90% | 22.41B | |
+0.35% | 22.28B | |
-5.48% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |
- Stock Market
- Equities
- CU6 Stock